Acasti Pharma Total Liabilities and Share Holders Equity 2014-2024 | ACST
Acasti Pharma total liabilities and share holders equity from 2014 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Acasti Pharma Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024 |
$73 |
| 2023 |
$79 |
| 2022 |
$129 |
| 2021 |
$62 |
| 2020 |
$23 |
| 2019 |
$37 |
| 2018 |
$18 |
| 2017 |
$20 |
| 2016 |
$22 |
| 2015 |
$33 |
| 2015 |
$ |
| 2014 |
$44 |
| 2014 |
$ |
| 2013 |
$12 |
| 2013 |
$ |
Acasti Pharma Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$70 |
| 2024-03-31 |
$73 |
| 2023-12-31 |
$76 |
| 2023-09-30 |
$78 |
| 2023-06-30 |
$73 |
| 2023-03-31 |
$79 |
| 2022-12-31 |
$117 |
| 2022-09-30 |
$121 |
| 2022-06-30 |
$125 |
| 2022-03-31 |
$129 |
| 2021-12-31 |
$114 |
| 2021-09-30 |
$120 |
| 2021-06-30 |
$60 |
| 2021-03-31 |
$62 |
| 2020-12-31 |
$30 |
| 2020-09-30 |
$14 |
| 2020-06-30 |
$20 |
| 2020-03-31 |
$23 |
| 2019-12-31 |
$29 |
| 2019-09-30 |
$29 |
| 2019-06-30 |
$29 |
| 2019-03-31 |
$37 |
| 2018-12-31 |
$45 |
| 2018-09-30 |
$15 |
| 2018-06-30 |
$21 |
| 2018-03-31 |
$18 |
| 2017-12-31 |
$21 |
| 2017-09-30 |
$16 |
| 2017-06-30 |
$17 |
| 2017-02-28 |
$20 |
| 2016-11-30 |
$16 |
| 2016-08-31 |
$18 |
| 2016-05-31 |
$20 |
| 2016-03-31 |
$22 |
| 2016-02-29 |
|
| 2015-12-31 |
$23 |
| 2015-09-30 |
$26 |
| 2015-06-30 |
$28 |
| 2015-03-31 |
$33 |
| 2014-12-31 |
$35 |
| 2014-09-30 |
$38 |
| 2014-06-30 |
$40 |
| 2014-03-31 |
$44 |
| 2014-02-28 |
|
| 2013-12-31 |
$25 |
| 2013-09-30 |
$25 |
| 2013-06-30 |
$11 |
| 2013-03-31 |
$12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.028B |
$0.000B |
|
Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
|
